These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6018961)

  • 1. The renal excretion of hydrogen ion in uric acid stone formers.
    Rapoport A; Crassweller PO; Husdan H; From GL; Zweig M; Johnson MD
    Metabolism; 1967 Feb; 16(2):176-88. PubMed ID: 6018961
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers.
    Robertson WG; Peacock M; Nordin BE
    Clin Sci; 1971 May; 40(5):365-74. PubMed ID: 5556093
    [No Abstract]   [Full Text] [Related]  

  • 3. Direct titrimetric determination of uric acid separately and in urine of patients containing stone.
    Shyam H; Saxena OC
    Ital J Biochem; 1973; 22(2):65-73. PubMed ID: 4771416
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
    Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes.
    Bobulescu IA; Maalouf NM; Capolongo G; Adams-Huet B; Rosenthal TR; Moe OW; Sakhaee K
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1498-503. PubMed ID: 24026180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent uric acid stones.
    Kamel KS; Cheema-Dhadli S; Shafiee MA; Davids MR; Halperin ML
    QJM; 2005 Jan; 98(1):57-68. PubMed ID: 15625355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The loss of circadian rhythmicity of urinary solute excretion in idiopathic stone formers.
    Sidhu H; Vaidyanathan S; Wangoo D; Thind SK; Nath R; Malakondaiah GC; Krishan K
    Br J Urol; 1989 Oct; 64(4):333-5. PubMed ID: 2819381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of uricine.
    Pinto B; Rocha E
    Invest Urol; 1977 Sep; 15(2):155-7. PubMed ID: 20424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased production and reduced urinary buffering of acid in uric acid stone formers is ameliorated by pioglitazone.
    Maalouf NM; Poindexter JR; Adams-Huet B; Moe OW; Sakhaee K
    Kidney Int; 2019 May; 95(5):1262-1268. PubMed ID: 30795852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diurnal variation in urine acidification differs between normal individuals and uric acid stone formers.
    Cameron M; Maalouf NM; Poindexter J; Adams-Huet B; Sakhaee K; Moe OW
    Kidney Int; 2012 Jun; 81(11):1123-30. PubMed ID: 22297671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic basis of renal-stone disease.
    Broadus AE; Thier SO
    N Engl J Med; 1979 Apr; 300(15):839-45. PubMed ID: 34098
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collection and handling of 24-hour urine specimens for measurement of analytes related to renal calculi.
    Ng RH; Menon M; Ladenson JH
    Clin Chem; 1984 Mar; 30(3):467-71. PubMed ID: 6697501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Urinary Inhibitor or Promoter Activity in Uric Acid Nephrolithiasis.
    Doizi S; Rodgers K; Poindexter J; Sakhaee K; Maalouf NM
    J Urol; 2016 Jun; 195(6):1799-804. PubMed ID: 26723865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Questionable significance of the chemical analysis of a single 24-hour urine sample in recurrent calcium oxalate nephrolithiasis].
    Riess C; Hess B; Binswanger U
    Klin Wochenschr; 1986 May; 64(9):411-6. PubMed ID: 3713110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the severity of renal stone disease and urine composition.
    Tiselius HG
    Eur Urol; 1979; 5(5):323-7. PubMed ID: 446508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary management of urinary risk factors in renal stone formers.
    Rao PN; Prendiville V; Buxton A; Moss DG; Blacklock NJ
    Br J Urol; 1982 Dec; 54(6):578-83. PubMed ID: 6295538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ribomononucleotides given orally on uric acid production in man.
    Gutman AB; Yü TF
    Adv Exp Med Biol; 1974; 41():401-5. PubMed ID: 4832563
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis.
    Sakhaee K; Adams-Huet B; Moe OW; Pak CY
    Kidney Int; 2002 Sep; 62(3):971-9. PubMed ID: 12164880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.